Genie Dubuk

VP, Customer Experience and Insights

Genie was appointed Vice President of Customer Experience and Insights in 2024, and first joined Cytokinetics in December of 2022.

Genie has a deep commercial background which includes over 20 years building teams, brands and organizations in the pharmaceutical and biotech industry. Most recently Genie served as Vice President, Business Unit Head Rare Disease at Alnylam where she led the U.S. launch of Givlaari® and Oxlumo®. Prior to this role, she held several leadership positions at Regeneron including Head of US and Global Cardiovascular Marketing where she led the U.S. and Global commercialization of Praluent®. Prior to Regeneron, Genie held various roles of increasing responsibility within Marketing and Global Commercialization at Astellas and Bristol Myers Squibb.

Genie received a B.S. in Biology from California State University East Bay and an M.B.A from San Jose State University (California).

A Bay Area transplant to the east coast, Genie resides in the Philadelphia, PA area with her French Bulldog Max. She enjoys domestic and international travel, including visiting family in the Bay Area.